Benedicte Sjo Tiselvoll is a PhD fellow at K2. She started in the fall of 2018 and was before this a research line student and completed her medical studies in the spring of 2018. She works at Bjørn Tore Gjertsen’s research group (Ths signaling-targeted therapy group), focusing on early treatment response in acute myelogenous leukemia (AML) using mass cytometry (CyTOF) ). If you want to say hello, she can be contacted by email: benedicte.tislevoll@uib.no